Insulin glargine in patients with severe hepato-gastroenterology diseases and hyperglycemia receiving parenteral nutrition.

Fatati, G; Mirri, E; Palazzi, M; Vendetti, A L; Pierotti, F; Weber, P; Mattei, R; Parillo, M; Coaccioli, S; Puxeddu, A

Fatati, G; Mirri, E; Palazzi, M; Vendetti, A L; Pierotti, F; Weber, P; Mattei, R; Parillo, M; Coaccioli, S; Puxeddu, A.

Affiliation

Fatati G; Diabetology, Dietetics and Clinical Nutrition Unit, Santa Maria Hospital Terni, Italy.

Clin Ter ; 157(6): 511-5, 2006.

Article in En | MEDLINE | ID: mdl-17228850

Subject(s)

Hyperglycemia/drug therapy; Hypoglycemic Agents/therapeutic use; Insulin/analogs & derivatives; Parenteral Nutrition; Aged; Aged, 80 and over; Blood Glucose/analysis; Data Interpretation, Statistical; Diabetes Mellitus, Type 1/complications; Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/drug therapy; Gastrointestinal Diseases/complications; Humans; Hyperglycemia/blood; Hyperglycemia/diagnosis; Hypoglycemic Agents/administration & dosage; Injections, Subcutaneous; Insulin/administration & dosage; Insulin/therapeutic use; Insulin Glargine; Insulin, Long-Acting; Liver Diseases/complications; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Trofoterapia Main subject: Parenteral Nutrition / Hyperglycemia / Hypoglycemic Agents / Insulin Type of study: Diagnostic_studies / Observational_studies Language: En Journal: Clin Ter Year: 2006 Type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links